Med-X Announces New Registrations of Flagship Nature-Cide Product Line in Caribbean Islands
Med-X Announces New Registrations of Flagship Nature-Cide Product Line in Caribbean Islands
Registration of Nature-Cide Across the Caribbean Enhances Global Presence while Enabling Caribbean Sustainability Goals
在整個加勒比地區註冊Nature-Cide增強了全球影響力，同時實現了加勒比地區的可持續發展目標
LOS ANGELES, CA / ACCESSWIRE / May 31, 2023 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that it has filed to register its flagship Nature-Cide pest control product line in several Caribbean islands, addressing an unaddressed adjacent market with heavy pest pressures and a strong commitment to sustainability.
加利福尼亞州洛杉磯/Accesswire/2023 年 5 月 31 日/ Med-X, Inc.， 一家針對害蟲防治、健康和保健市場的全天然綠色場景解決方案的領先創新者，今天宣佈已申請註冊其旗艦產品 滅絕自然 害蟲防治產品線遍佈多個加勒比海島嶼，以應對未得到解決的鄰近市場，蟲害壓力巨大，對可持續發展的堅定承諾。
Med-X, through its multiple distribution partners, has proceeded to register its primary Nature-Cide products across Barbados, Guyana, St. Lucia and Trinidad, with an approval and shipments already moving into Guyana. Registration is a mandatory process for pest control products in many international jurisdictions, allowing Med-X to gain government approval to use its products in local markets.
Med-X已通過其多個分銷合作伙伴，着手在巴巴多斯、圭亞那、聖盧西亞和特立尼達註冊其主要的Nature-Cide產品，已獲得批准，貨物已運往圭亞那。在許多國際司法管轄區，註冊是害蟲防治產品的強制性程序，這使Med-X能夠獲得政府批准才能在當地市場使用其產品。
This strategic decision reflects the growing demand for effective pest management solutions in jurisdictions with heavy pest pressures that prioritize environmental sustainability and the well-being of communities. Med-X began testing and introducing Nature-Cide into various regions world-wide over the last couple of years, which has now garnered great interest and demand to contribute to the reduction of chemical-based pest control methods with effective all-natural solutions, protecting both people and the environment.
這一戰略決策反映了害蟲壓力沉重的司法管轄區對有效害蟲管理解決方案的需求不斷增長，這些司法管轄區優先考慮環境可持續性和社區福祉。在過去的幾年中，Med-X開始測試Nature-Cide並將其引入全球各個地區，現在，Nature-Cide引起了極大的興趣和需求，旨在通過有效的全天然解決方案爲減少基於化學的害蟲控制方法做出貢獻，保護人類和環境。
Matthew Mills, Chief Executive Officer of Med-X, said: "We are thrilled to announce the beginning of our world-wide expansion with a first step into the Caribbean islands, to supply our flagship Nature-Cide solutions to a largely untapped, niche market with significant white space for adoption across the region. We look forward to registering and launching our portfolio of Nature-Cide products across a variety or regions that are demanding solutions that are environmentally friendly as we strive to create value for our shareholders over the long-term.
Med-X首席執行官Matthew Mills表示：“我們很高興地宣佈，我們的全球擴張已開始，這是進入加勒比海島嶼的第一步，向一個基本上尚未開發的利基市場提供我們的旗艦Nature-Cide解決方案，該地區有大量的空白空間可供採用。我們期待在各個地區註冊並推出我們的Nature-Cide產品組合，這些產品組合需要環保的解決方案，因爲我們正在努力爲股東長期創造價值。
"Our mission has always been to provide effective pest control solutions that are safe, environmentally friendly, and sustainable. By partnering with local community leaders and their regulatory authorities, we are taking a step forward in achieving our goal of reducing reliance on harmful chemicals in pest management while providing necessary relief from heavy pest pressures across the Caribbean and beyond," concluded Mills.
“我們的使命一直是提供安全、環保和可持續的有效害蟲防治解決方案。通過與當地社區領袖及其監管機構合作，我們在實現減少害蟲管理中對有害化學物質的依賴的目標方面向前邁出了一步，同時爲整個加勒比地區及其他地區的巨大害蟲壓力提供必要的緩解，” 米爾斯總結道。
About Med-X, Inc.
關於 Med-X, Inc.
Med-X, Inc. is a leading innovator of biological pest control solutions addressing both consumer and professional markets globally. Nature-Cide - the Company's flagship product line - is a safer, all-natural alternative to conventional chemical products, formulated to kill or repel a wide variety of pests. Med-X's comprehensive go-to-market strategy includes leveraging strategic partnerships alongside an integrated e-commerce, brick and mortar and on-site services presence in key markets. For more information, please visit our website at .
Med-X, Inc. 是生物害蟲防治解決方案的領先創新者，面向全球消費者和專業市場。Nature-Cide是公司的旗艦產品線，是傳統化學產品的更安全、全天然的替代品，其配方旨在殺死或擊退各種害蟲。Med-X 的全面進入市場戰略包括利用戰略合作伙伴關係，以及在關鍵市場開展綜合電子商務、實體店和現場服務。欲瞭解更多信息，請訪問我們的網站 。
Disclaimer and Forward-Looking Statements
免責聲明和前瞻性陳述
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). This announcement is being issued in accordance with Rule 135 of the Securities Act. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events.
本新聞稿不構成出售要約或徵求購買任何證券的要約。任何證券的要約、招標或要約購買或任何出售都將根據經修訂的1933年《證券法》（“證券法”）的註冊要求提出。本公告是根據《證券法》第135條發佈的。本新聞稿可能包含有關預計業務業績、經營業績、財務狀況和公司其他方面的前瞻性陳述，用 “預期”、“預期” 和 “預測” 等語言表達。請注意，此類陳述僅是估計值，無法保證前瞻性陳述所陳述或暗示的結果會由公司實際實現。前瞻性陳述可能基於被證明是錯誤的管理假設。公司及其業務面臨其無法控制的重大風險和潛在事件，這些風險和潛在事件將導致預期業績與實際業績之間存在重大差異，包括公司蒙受營業虧損和遇到意想不到的重大不利事件。
Investor Relations Contact
投資者關係聯繫人
Lucas Zimmerman
Director
MZ Group - MZ North America
262-357-2918
MXRX@mzgroup.us
盧卡斯·齊默爾曼
導演
MZ 集團-MZ 北美
262-357-2918
MXRX@mzgroup.us
SOURCE: Med-X, Inc.
來源： Med-X, Inc.
譯文內容由第三人軟體翻譯。